[{"AccountsPayableCurrentAndNoncurrent_0_Q2_USD":3042000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.687,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.687,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.696,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.696,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":344000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-21985000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6523000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4327000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":35000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":40000.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_2_Q2_USD":63512000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":159000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":40000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":1115000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1000.0,"OtherNonoperatingExpense_2_Q2_USD":4000.0,"OtherNonoperatingExpense_1_Q2_USD":3000.0,"OtherLiabilitiesCurrent_0_Q2_USD":120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.012,"OtherAssetsNoncurrent_0_Q2_USD":3090000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.01,"TemporaryEquitySharesAuthorized_0_Q2_shares":10000000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q2_USD":-9000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"StockholdersEquityNoteStockSplitConversionRatio1_0_Q2_pure":0.32,"StockholdersEquity_0_Q2_USD":-21578000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.04,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.69,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":2770954.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":47439000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":2.72,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":41250.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":829000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.69,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2770954.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":47439000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2541849.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":1768000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.01,"OperatingIncomeLoss_2_Q2_USD":-8554000.0,"OperatingIncomeLoss_1_Q2_USD":-5774000.0,"OperatingExpenses_2_Q2_USD":8554000.0,"DeferredCosts_0_Q2_USD":3000000.0,"ConversionOfStockSharesIssued1_0_Q2_shares":14182854.0,"CommonStockSharesOutstanding_0_Q2_shares":243076.0,"CommonStockSharesIssued_0_Q2_shares":243076.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":18721808.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":54577000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":59150000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":59150000.0,"Cash_0_Q2_USD":1400000.0,"AssetsCurrent_0_Q2_USD":59309000.0,"Assets_0_Q2_USD":62434000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16953808.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":344000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":321000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":321000.0,"AdditionalPaidInCapital_0_Q2_USD":407000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":5000.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":9000.0,"DeferredOfferingCosts_0_Q2_USD":297000.0,"Depreciation_2_Q2_USD":4000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-23.8,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-35.29,"OperatingExpenses_1_Q2_USD":5774000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-8578000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-5784000.0,"NetIncomeLoss_2_Q2_USD":-8556000.0,"NetIncomeLoss_1_Q2_USD":-5775000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-7780000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-40000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":62397000.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":57800000.0,"LiabilitiesCurrent_0_Q2_USD":4193000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":243076.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":62434000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":2000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":56000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":74000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-5000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":563000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":2031000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1447000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":9400000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":258000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":2000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":243076.0,"Ticker":"AVTE","CIK":"1798749","name":"AEROVATE THERAPEUTICS, INC.","OfficialName":"Aerovate Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"409850498.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]